Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
0.6580
-0.0120 (-1.79%)
Mar 31, 2025, 1:37 PM EDT - Market open
Biodesix Market Cap
Biodesix has a market cap or net worth of $96.05 million as of March 31, 2025. Its market cap has decreased by -32.60% in one year.
Market Cap
96.05M
Enterprise Value
132.58M
1-Year Change
-32.60%
Ranking
Category
Stock Price
$0.66
Market Cap Chart
Since October 28, 2020, Biodesix's market cap has decreased from $336.31M to $96.05M, a decrease of -71.44%. That is a compound annual growth rate of -24.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 97.81M | -56.06% |
| Dec 31, 2024 | 222.56M | 33.69% |
| Dec 29, 2023 | 166.48M | -5.38% |
| Dec 30, 2022 | 175.94M | 23.06% |
| Dec 31, 2021 | 142.97M | -73.28% |
| Dec 31, 2020 | 535.07M | 59.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |